Our CEO Rob Claar talks about opportunities for global innovators in Japan's MedTech marketHekaBio2023年8月3日読了時間: 0分
HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation~ Accelerating Access to Innovative Therapies in Japan through Alfresa Group’s ‘ Total Supply Chain Service’ ~ Read the news release on...
HekaBio Welcomes Deron Wolfe as Chief Financial OfficerWe are pleased to announce that Deron Wolfe has joined HekaBio K.K. as Chief Financial Officer. Deron brings nearly three decades of...
Commenti